FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to medicine, namely to veterinary science, and can be applicable for using a composition for protection against an infection caused by Lawsonia intracellularis. That is ensured by using a non-living composition containing carbohydrate which is also found in living cells of Lawsonia intracellularis in association with an external cell membrane of the above cells. The vaccine is presented in the form applicable for intramuscular introduction, and contains an oil-in-water adjuvant containing oil drops with an average size of 400 nm.
EFFECT: using the given non-living composition leads to effective immunisation in intramuscular introduction with using small drops of the oil-in-water adjuvant which provides protection of animals against Lawsonia intracellularis.
7 cl, 9 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| VACCINE FOR PROTECTION AGAINST LAWSONIAINTRACELLULARIS, MYCOPLASMA HYOPNEUMONIAE AND PORCINE CIRCOVIRUS | 2009 |
|
RU2496520C2 |
| Lawsonia-BASED VACCINE AND METHODS OF ITS APPLICATION | 2006 |
|
RU2420310C2 |
| VACCINE FOR USE AGAINST SUBCLINICAL INFECTION LAWSONIA IN PIGS | 2016 |
|
RU2709197C2 |
| VACCINE FOR USE AGAINST SUBCLINICAL LAWSONIA INFECTION IN PIGS | 2016 |
|
RU2723022C2 |
| SWINE VACCINE AGAINST PRRS AND LAWSONIA INTRACELLULARIS | 2014 |
|
RU2655615C1 |
| COMBINED PORCINE VACCINE | 2017 |
|
RU2761453C2 |
| VACCINES CONTAINING PORCINE PATHOGENS FOR ASSOCIATED UNMIXED USE | 2018 |
|
RU2756767C2 |
| VACCINE AGAINST LAWSONIA INTRACELLULARIS AND PORCINE CIRCOVIRUS 2 | 2014 |
|
RU2672251C1 |
| PORCINE CIRCOVIRUS TYPE 2 VACCINE | 2014 |
|
RU2712155C2 |
| Lawsonia intracellulars OF EUROPEAN ORIGIN AND BASED VACCINES, DIAGNOSTIC AGENTS AND METHODS OF APPLICATION THEREOF | 2004 |
|
RU2420570C2 |
